全文获取类型
收费全文 | 1438篇 |
免费 | 129篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 186篇 |
妇产科学 | 25篇 |
基础医学 | 221篇 |
口腔科学 | 26篇 |
临床医学 | 139篇 |
内科学 | 298篇 |
皮肤病学 | 124篇 |
神经病学 | 52篇 |
特种医学 | 204篇 |
外科学 | 122篇 |
综合类 | 13篇 |
预防医学 | 85篇 |
眼科学 | 17篇 |
药学 | 34篇 |
中国医学 | 1篇 |
肿瘤学 | 60篇 |
出版年
2019年 | 20篇 |
2018年 | 19篇 |
2015年 | 21篇 |
2014年 | 18篇 |
2013年 | 32篇 |
2012年 | 25篇 |
2011年 | 35篇 |
2010年 | 33篇 |
2009年 | 44篇 |
2008年 | 37篇 |
2007年 | 56篇 |
2006年 | 41篇 |
2005年 | 35篇 |
2004年 | 34篇 |
2003年 | 30篇 |
2002年 | 33篇 |
2001年 | 30篇 |
2000年 | 32篇 |
1999年 | 37篇 |
1998年 | 46篇 |
1997年 | 42篇 |
1996年 | 50篇 |
1995年 | 46篇 |
1994年 | 54篇 |
1993年 | 35篇 |
1992年 | 32篇 |
1991年 | 33篇 |
1990年 | 31篇 |
1989年 | 60篇 |
1988年 | 52篇 |
1987年 | 45篇 |
1986年 | 45篇 |
1985年 | 35篇 |
1984年 | 33篇 |
1983年 | 34篇 |
1982年 | 19篇 |
1981年 | 13篇 |
1980年 | 19篇 |
1979年 | 28篇 |
1978年 | 19篇 |
1977年 | 13篇 |
1976年 | 18篇 |
1975年 | 20篇 |
1974年 | 17篇 |
1973年 | 15篇 |
1971年 | 16篇 |
1970年 | 12篇 |
1969年 | 25篇 |
1968年 | 15篇 |
1967年 | 15篇 |
排序方式: 共有1612条查询结果,搜索用时 31 毫秒
31.
C F Salinas L Bartoshesky H B Othersen L Leape M Feingold R J Jorgenson 《American journal of diseases of children (1960)》1979,133(5):514-517
In two unrelated families, there was familial occurrence of gastroschisis. In one family, a boy and girl were affected and there was a family history of stillbirth, abortion, prematurity, and esophageal obstruction. In the second family, two boys were affected and there was a family history of spontaneous abortion, inguinal hernia, and umbilical hernia. The recurrence of gastroschisis, generally considered a sporadic congenital effect, suggests that the condition may be genetic in nature. Furthermore, the pedigree of one of the families suggests that gastroschisis may be a severe expression of umbilical hernia or other abdominal wall defects. Autosomal dominant inheritance with variable expressivity or multifactorial inheritance may explain the occurrence of gastroschisis in the two families. Thus, a family history of abdominal wall defects may increase the risk for gastroschisis. 相似文献
32.
Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee 总被引:5,自引:1,他引:5
F. Eisinger N. Alby A. Bremond J. Dauplat M. Espié P. Janiaud F. Kuttenn J.-P. Lebrun J.-P. Lefranc J. Pierret H. Sobol D. Stoppa-Lyonnet D. Thouvenin H. Tristant J. Feingold 《Annals of oncology》1998,9(9):939-950
Background and purpose: Almost 10% of breast and ovarian cancers are familial, and the majority are linked to BRCA1 and BRCA2 germline mutations. Despite uncertainty about the management of female gene carriers, consensus guidelines have been established to assist practitioners and consultees in making health care decisions.Methodology: The Ad Hoc Committee was composed of 14 experts appointed by the French National Institute for Health and Medical Research, all of whom attended eleven workshops at which more than 3500 articles were systematically analyzed. Five additional experts critically analysed the first version of the report.Criteria and decision process: On a probability scale of the risk of developing breast or ovarian cancers, two thresholds were defined for use in determining whether an intervention would be worthwhile. The first is the threshold above which an intervention can be envisaged or recommended, and the second is the one below which an intervention can be ruled out; between the two, the decision has to be made on a case-by-case basis.Screening and preventive strategies analyzed: With respect to breast cancer: 1) hormonal interventions; 2) primary prevention (diet, family planning and chemoprevention); 3) screening (breast self-examination, clinician breast examination, tumor markers, imaging); 4) prophylactic mastectomy. With respect to ovarian cancer: 1) hormonal stimulation; 2) screening (clinical screening, ultrasound and tumor markers); 3) prophylactic oophorectomy.Main conclusions: For each strategy the following points were addressed: the information to be given to the consultee, the procedure and the indications. In addition, the committee's opinion about BRCA1 and BRCA2 mutation screening is that population-based, or even large-scale, implementation are not justified. Although no scientific evidence is available, the committee feels that specific management is indispensable and advocates the use of defined and evaluated procedures, and participation in clinical trials. 相似文献
33.
Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers 总被引:3,自引:4,他引:3
Tang DL; Rundle A; Warburton D; Santella RM; Tsai WY; Chiamprasert S; Hsu YZ; Perera FP 《Carcinogenesis》1998,19(11):1949-1953
This molecular epidemiologic case-control study of lung cancer incorporated
three complementary biomarkers: the glutathione S- transferase M1 (GSTM1)
null genotype, a potential marker of susceptibility, and polycyclic
aromatic hydrocarbon-DNA adducts (PAH- DNA) and sister chromatid exchanges
(SCE), both indicators of environmentally induced genetic damage.
Associations between biomarkers and lung cancer were investigated, as were
possible gene-environment interactions between the GSTM1 null genotype and
tobacco smoke exposure. Subjects included 136 primary non-small cell lung
cancer surgical patients and 115 controls at the Columbia Presbyterian
Medical Center. Questionnaire and Tumor Registry data, pre-treatment blood
samples and biomarker measurements on blood were obtained. Overall, GSTM1
null genotype was significantly associated with lung cancer [odds ratio
(OR) = 2.04, 95% confidence interval (CI) = 1.13-3.68]. ORs for GSTM1 and
lung cancer were significant in females (2.50, 1.09-5.72) and smokers
(2.25, 1.11-4.54) and not significant in males (1.4, 0.58-3.38) and
non-smokers (0.88, 0.18-4.33). However, ORs for males versus females and
smokers versus non-smokers did not differ significantly. The OR for GSTM1
and lung cancer in female smokers was 3.03 (1.09- 8.40), compared with 1.42
(0.53-4.06) in male smokers. In contrast to PAH-DNA adducts in leukocytes,
SCE did not differ between cases and controls. Neither biomarker differed
significantly between the two GSTM1 genotypes. The combined effect of
elevated PAH-DNA adducts and GSTM1 genotype on case-control status (16.19,
1.2-115) appeared multiplicative. Results suggest that the effect of the
GSTM1 null genotype is greatest in female smokers, which is consistent with
other evidence that indicates that women are at higher risk of lung cancer
than males, given equal smoking. Persons with both the GSTM1 deletion and
elevated PAH-DNA adducts may represent a sensitive subpopulation with
respect to carcinogens in tobacco smoke and other environmental media.
相似文献
34.
S Gananadha TDB Yan J Zhao P Clingan D Glenn DL Morris 《Journal of Medical Imaging and Radiation Oncology》2005,49(5):396-399
Hepatic artery infusion (HAI) chemotherapy is associated with higher response rates compared to systemic chemotherapy in those patients with unresectable liver malignancies. Operative hepatic artery catheter (HAC) insertion has significant morbidity and mortality, especially in patients with high‐volume disease, some of whom may not respond to HAI chemotherapy. We report our experience in 45 patients with high‐volume liver disease who were initially treated with HAI chemotherapy via a radiologically placed temporary HAC to try to select the responders who then went on to have an operative HAC. In these 45 patients who had 62 radiologically placed HAC, we found very few major complications, and certainly no complications such as cholecystitis, vascular or malperfusion problems. 相似文献
35.
36.
37.
38.
39.
40.
We reviewed the short-term response to and safety of protease inhibitor (PI) therapy in HIV-infected children by performing a retrospective chart review of open-label PI containing combination therapy at two urban pediatric HIV centers. Seventy HIV-infected children received 101 PI containing antiretroviral therapy (ART) combinations. Main outcome measures were follow-up CD4 counts, viral loads, and patient or caregiver reported compliance. During follow-up, treatment with PI ART was associated with a mean maximal increase in CD4+ lymphocyte count of 454 x 10(6)/L and a mean maximal decrease in viral load of 1.76 log units. Of the 32 patients who achieved undetectable viral loads, 28 (87.5%) remained undetectable through a mean follow-up of 8.9 months. Patients who reported good compliance achieved a higher rate of response (92.6%) than those who reported poor compliance (61.5%). Of 14 changes made to a second PI because of treatment failure, 11 (78.6%) resulted in a positive response to the second regimen. Nineteen of 101 courses of PI therapy resulted in significant side effects, including renal complications in 8 of 21 patients treated with indinavir. PI ART was associated with substantial short-term improvement in immunological and virological parameters in this heavily pretreated cohort, with 40% of patients maintaining an undetectable viral load after 9 months of therapy. Patients who failed one PI regimen usually responded to a second regimen. There was a significant rate of side effects from PI treatment. 相似文献